Abstract

Chronic kidney disease (CKD) results in the impaired filtration of metabolites, which may be toxic or harmful to organs/tissues. The objective of this study was to perform unbiased 1H nuclear magnetic resonance (NMR)-based metabolomics profiling of tissues from mice with CKD. Five-month-old male C57BL6J mice were placed on either a casein control diet or adenine-supplemented diet to induce CKD for 24 weeks. CKD was confirmed by significant increases in blood urea nitrogen (24.1 ± 7.7 vs. 105.3 ± 18.3 mg/dL, p < 0.0001) in adenine-fed mice. Following this chronic adenine diet, the kidney, heart, liver, and quadriceps muscles were rapidly dissected; snap-frozen in liquid nitrogen; and the metabolites were extracted. Metabolomic profiling coupled with multivariate analyses confirm clear separation in both aqueous and organic phases between control and CKD mice. Severe energetic stress and apparent impaired mitochondrial metabolism were observed in CKD kidneys evidenced by the depletion of ATP and NAD+, along with significant alterations in tricarboxylic acid (TCA) cycle intermediates. Altered amino acid metabolism was observed in all tissues, although significant differences in specific amino acids varied across tissue types. Taken together, this study provides a metabolomics fingerprint of multiple tissues from mice with and without severe CKD induced by chronic adenine feeding.

Highlights

  • Chronic kidney disease (CKD) impacts an estimated 8–16% of the world’s population [1] and is a significant risk factor for mortality [2]

  • Severe energetic stress and apparent impaired mitochondrial metabolism were observed in CKD kidneys evidenced by the depletion of ATP and NAD+, along with significant alterations in tricarboxylic acid (TCA) cycle intermediates

  • This study provides a metabolomics fingerprint of multiple tissues from mice with and without severe CKD induced by chronic adenine feeding

Read more

Summary

Introduction

Chronic kidney disease (CKD) impacts an estimated 8–16% of the world’s population [1] and is a significant risk factor for mortality [2]. CKD has no cure, with the available treatment options being limited to chronic dialysis or kidney transplant. In regards to the latter option, available transplant numbers are far outpaced by the increasing prevalence of CKD. The impaired glomerular filtration that accompanies CKD results in the retention and accumulation of metabolic by-products, which are either produced endogenously or ingested. Many of these metabolic by-products have been described as uremic toxins because of their harmful effects on tissues/organs [3,4,5,6,7,8,9]. Some of these metabolites have been reported to disrupt cellular metabolic pathways [8,10,11,12,13,14,15,16,17], which may be especially harmful to organs with high levels of energy (ATP) demand, such as the heart, kidney, liver, and skeletal muscles, which, together, account for ~60–65% of the daily energy expenditure

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call